IBDEI2VK ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,45859,0)
;;=I48.0^^173^2287^7
;;^UTILITY(U,$J,358.3,45859,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45859,1,3,0)
;;=3^Atrial Fibrillation,Paroxysmal
;;^UTILITY(U,$J,358.3,45859,1,4,0)
;;=4^I48.0
;;^UTILITY(U,$J,358.3,45859,2)
;;=^90473
;;^UTILITY(U,$J,358.3,45860,0)
;;=Z86.711^^173^2287^17
;;^UTILITY(U,$J,358.3,45860,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45860,1,3,0)
;;=3^Personal Hx of Pulmonary Embolism
;;^UTILITY(U,$J,358.3,45860,1,4,0)
;;=4^Z86.711
;;^UTILITY(U,$J,358.3,45860,2)
;;=^5063474
;;^UTILITY(U,$J,358.3,45861,0)
;;=Z95.2^^173^2287^18
;;^UTILITY(U,$J,358.3,45861,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45861,1,3,0)
;;=3^Presence of Prosthetic Heart Valve
;;^UTILITY(U,$J,358.3,45861,1,4,0)
;;=4^Z95.2
;;^UTILITY(U,$J,358.3,45861,2)
;;=^5063670
;;^UTILITY(U,$J,358.3,45862,0)
;;=I48.92^^173^2287^9
;;^UTILITY(U,$J,358.3,45862,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45862,1,3,0)
;;=3^Atrial Flutter,Unspec
;;^UTILITY(U,$J,358.3,45862,1,4,0)
;;=4^I48.92
;;^UTILITY(U,$J,358.3,45862,2)
;;=^5007230
;;^UTILITY(U,$J,358.3,45863,0)
;;=D68.8^^173^2287^11
;;^UTILITY(U,$J,358.3,45863,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45863,1,3,0)
;;=3^Coagulation Defects,Oth Specified
;;^UTILITY(U,$J,358.3,45863,1,4,0)
;;=4^D68.8
;;^UTILITY(U,$J,358.3,45863,2)
;;=^5002363
;;^UTILITY(U,$J,358.3,45864,0)
;;=D68.318^^173^2287^13
;;^UTILITY(U,$J,358.3,45864,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45864,1,3,0)
;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag/Antib/Inhib
;;^UTILITY(U,$J,358.3,45864,1,4,0)
;;=4^D68.318
;;^UTILITY(U,$J,358.3,45864,2)
;;=^340504
;;^UTILITY(U,$J,358.3,45865,0)
;;=D68.32^^173^2287^12
;;^UTILITY(U,$J,358.3,45865,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45865,1,3,0)
;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
;;^UTILITY(U,$J,358.3,45865,1,4,0)
;;=4^D68.32
;;^UTILITY(U,$J,358.3,45865,2)
;;=^5002357
;;^UTILITY(U,$J,358.3,45866,0)
;;=I10.^^173^2287^14
;;^UTILITY(U,$J,358.3,45866,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45866,1,3,0)
;;=3^Hypertension,Essential
;;^UTILITY(U,$J,358.3,45866,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,45866,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,45867,0)
;;=I82.401^^173^2287^3
;;^UTILITY(U,$J,358.3,45867,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45867,1,3,0)
;;=3^Acute Embolism/Thrombos Deep Veins,Rt Lower Extrem,Unspec
;;^UTILITY(U,$J,358.3,45867,1,4,0)
;;=4^I82.401
;;^UTILITY(U,$J,358.3,45867,2)
;;=^5007854
;;^UTILITY(U,$J,358.3,45868,0)
;;=I82.402^^173^2287^2
;;^UTILITY(U,$J,358.3,45868,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45868,1,3,0)
;;=3^Acute Embolism/Thrombos Deep Veins,Lt Lower Extrem,Unspec
;;^UTILITY(U,$J,358.3,45868,1,4,0)
;;=4^I82.402
;;^UTILITY(U,$J,358.3,45868,2)
;;=^5007855
;;^UTILITY(U,$J,358.3,45869,0)
;;=I82.890^^173^2287^1
;;^UTILITY(U,$J,358.3,45869,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45869,1,3,0)
;;=3^Acute Embolism/Thromb of Other Specified Veins
;;^UTILITY(U,$J,358.3,45869,1,4,0)
;;=4^I82.890
;;^UTILITY(U,$J,358.3,45869,2)
;;=^5007938
;;^UTILITY(U,$J,358.3,45870,0)
;;=I82.891^^173^2287^10
;;^UTILITY(U,$J,358.3,45870,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45870,1,3,0)
;;=3^Chronic Embolism/Thrombo of Other Specified Veins
;;^UTILITY(U,$J,358.3,45870,1,4,0)
;;=4^I82.891
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2VK 3763 printed Sep 23, 2025@20:12:41 Page 2
IBDEI2VK ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,45859,0)
+2 ;;=I48.0^^173^2287^7
+3 ;;^UTILITY(U,$J,358.3,45859,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,45859,1,3,0)
+6 ;;=3^Atrial Fibrillation,Paroxysmal
+7 ;;^UTILITY(U,$J,358.3,45859,1,4,0)
+8 ;;=4^I48.0
+9 ;;^UTILITY(U,$J,358.3,45859,2)
+10 ;;=^90473
+11 ;;^UTILITY(U,$J,358.3,45860,0)
+12 ;;=Z86.711^^173^2287^17
+13 ;;^UTILITY(U,$J,358.3,45860,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,45860,1,3,0)
+16 ;;=3^Personal Hx of Pulmonary Embolism
+17 ;;^UTILITY(U,$J,358.3,45860,1,4,0)
+18 ;;=4^Z86.711
+19 ;;^UTILITY(U,$J,358.3,45860,2)
+20 ;;=^5063474
+21 ;;^UTILITY(U,$J,358.3,45861,0)
+22 ;;=Z95.2^^173^2287^18
+23 ;;^UTILITY(U,$J,358.3,45861,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,45861,1,3,0)
+26 ;;=3^Presence of Prosthetic Heart Valve
+27 ;;^UTILITY(U,$J,358.3,45861,1,4,0)
+28 ;;=4^Z95.2
+29 ;;^UTILITY(U,$J,358.3,45861,2)
+30 ;;=^5063670
+31 ;;^UTILITY(U,$J,358.3,45862,0)
+32 ;;=I48.92^^173^2287^9
+33 ;;^UTILITY(U,$J,358.3,45862,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,45862,1,3,0)
+36 ;;=3^Atrial Flutter,Unspec
+37 ;;^UTILITY(U,$J,358.3,45862,1,4,0)
+38 ;;=4^I48.92
+39 ;;^UTILITY(U,$J,358.3,45862,2)
+40 ;;=^5007230
+41 ;;^UTILITY(U,$J,358.3,45863,0)
+42 ;;=D68.8^^173^2287^11
+43 ;;^UTILITY(U,$J,358.3,45863,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,45863,1,3,0)
+46 ;;=3^Coagulation Defects,Oth Specified
+47 ;;^UTILITY(U,$J,358.3,45863,1,4,0)
+48 ;;=4^D68.8
+49 ;;^UTILITY(U,$J,358.3,45863,2)
+50 ;;=^5002363
+51 ;;^UTILITY(U,$J,358.3,45864,0)
+52 ;;=D68.318^^173^2287^13
+53 ;;^UTILITY(U,$J,358.3,45864,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,45864,1,3,0)
+56 ;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag/Antib/Inhib
+57 ;;^UTILITY(U,$J,358.3,45864,1,4,0)
+58 ;;=4^D68.318
+59 ;;^UTILITY(U,$J,358.3,45864,2)
+60 ;;=^340504
+61 ;;^UTILITY(U,$J,358.3,45865,0)
+62 ;;=D68.32^^173^2287^12
+63 ;;^UTILITY(U,$J,358.3,45865,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,45865,1,3,0)
+66 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
+67 ;;^UTILITY(U,$J,358.3,45865,1,4,0)
+68 ;;=4^D68.32
+69 ;;^UTILITY(U,$J,358.3,45865,2)
+70 ;;=^5002357
+71 ;;^UTILITY(U,$J,358.3,45866,0)
+72 ;;=I10.^^173^2287^14
+73 ;;^UTILITY(U,$J,358.3,45866,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,45866,1,3,0)
+76 ;;=3^Hypertension,Essential
+77 ;;^UTILITY(U,$J,358.3,45866,1,4,0)
+78 ;;=4^I10.
+79 ;;^UTILITY(U,$J,358.3,45866,2)
+80 ;;=^5007062
+81 ;;^UTILITY(U,$J,358.3,45867,0)
+82 ;;=I82.401^^173^2287^3
+83 ;;^UTILITY(U,$J,358.3,45867,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,45867,1,3,0)
+86 ;;=3^Acute Embolism/Thrombos Deep Veins,Rt Lower Extrem,Unspec
+87 ;;^UTILITY(U,$J,358.3,45867,1,4,0)
+88 ;;=4^I82.401
+89 ;;^UTILITY(U,$J,358.3,45867,2)
+90 ;;=^5007854
+91 ;;^UTILITY(U,$J,358.3,45868,0)
+92 ;;=I82.402^^173^2287^2
+93 ;;^UTILITY(U,$J,358.3,45868,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,45868,1,3,0)
+96 ;;=3^Acute Embolism/Thrombos Deep Veins,Lt Lower Extrem,Unspec
+97 ;;^UTILITY(U,$J,358.3,45868,1,4,0)
+98 ;;=4^I82.402
+99 ;;^UTILITY(U,$J,358.3,45868,2)
+100 ;;=^5007855
+101 ;;^UTILITY(U,$J,358.3,45869,0)
+102 ;;=I82.890^^173^2287^1
+103 ;;^UTILITY(U,$J,358.3,45869,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,45869,1,3,0)
+106 ;;=3^Acute Embolism/Thromb of Other Specified Veins
+107 ;;^UTILITY(U,$J,358.3,45869,1,4,0)
+108 ;;=4^I82.890
+109 ;;^UTILITY(U,$J,358.3,45869,2)
+110 ;;=^5007938
+111 ;;^UTILITY(U,$J,358.3,45870,0)
+112 ;;=I82.891^^173^2287^10
+113 ;;^UTILITY(U,$J,358.3,45870,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,45870,1,3,0)
+116 ;;=3^Chronic Embolism/Thrombo of Other Specified Veins
+117 ;;^UTILITY(U,$J,358.3,45870,1,4,0)
+118 ;;=4^I82.891
